Liveramp Financials
This page shows Liveramp (RAMP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
High gross margins and minimal reinvestment needs turn a near-breakeven income statement into meaningful cash generation.
Between FY2023 and FY2025, gross margin barely moved while operating margin improved by nearly22.0% -points, pointing to an overhead reset rather than richer unit economics. That matters because operating cash flow reached$154M in FY2025 with net income at-$814K , showing an asset-light model where low capex lets cash generation look much healthier than reported profit.
Because gross margin barely changed across the last three years, the swing from deep losses to breakeven was driven more by overhead restraint than by a richer revenue mix. In FY2025, operating margin of
Cash of
Financial Health Signals
Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Liveramp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Liveramp has an operating margin of 10.3%, meaning the company retains $10 of operating profit per $100 of revenue. This results in a moderate score of 35/100, indicating healthy but not exceptional operating efficiency. This is up from 0.7% the prior year.
Liveramp's revenue grew 9.0% year-over-year to $812.9M, a solid pace of expansion. This earns a growth score of 52/100.
Liveramp carries a low D/E ratio of 0.33, meaning only $0.33 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 95/100, indicating a strong balance sheet with room for future borrowing.
Liveramp's current ratio of 2.47 indicates adequate short-term liquidity, earning a score of 46/100. The company can meet its near-term obligations, though with limited headroom.
Liveramp converts 20.5% of revenue into free cash flow ($166.4M). This strong cash generation earns a score of 74/100.
Liveramp generates a 15.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 28/100. This is up from -0.1% the prior year.
Liveramp scores 7.01, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.3B) relative to total liabilities ($322.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Liveramp passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Liveramp generates $1.15 in operating cash flow ($167.8M OCF vs $146.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Liveramp earns $2608.3 in operating income for every $1 of interest expense ($83.5M vs $32K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Liveramp generated $812.9M in revenue in fiscal year 2026. This represents an increase of 9.0% from the prior year.
Liveramp's EBITDA was $96.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 328.4% from the prior year.
Liveramp reported $146.0M in net income in fiscal year 2026. This represents an increase of 18030.2% from the prior year.
Liveramp earned $2.24 per diluted share (EPS) in fiscal year 2026. This represents an increase of 22500.0% from the prior year.
Cash & Balance Sheet
Liveramp generated $166.4M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 8.8% from the prior year.
Liveramp held $379.5M in cash against $0 in long-term debt as of fiscal year 2026.
Liveramp had 60M shares outstanding in fiscal year 2026.
Margins & Returns
Liveramp's gross margin was 70.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the prior year.
Liveramp's operating margin was 10.3% in fiscal year 2026, reflecting core business profitability. This is up 9.6 percentage points from the prior year.
Liveramp's net profit margin was 17.9% in fiscal year 2026, showing the share of revenue converted to profit. This is up 18.1 percentage points from the prior year.
Liveramp's ROE was 15.0% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 15.1 percentage points from the prior year.
Capital Allocation
Liveramp invested $148.1M in research and development in fiscal year 2026. This represents a decrease of 16.1% from the prior year.
Liveramp spent $194.5M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 92.2% from the prior year.
Liveramp invested $1.4M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 32.1% from the prior year.
RAMP Income Statement
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $206.1M-2.9% | $212.2M+6.2% | $199.8M+2.6% | $194.8M+3.2% | $188.7M-3.4% | $195.4M+5.4% | $185.5M+5.4% | $176.0M |
| Cost of Revenue | $60.5M+1.5% | $59.7M+0.1% | $59.6M+2.2% | $58.3M+0.7% | $57.9M+5.3% | $55.0M+7.3% | $51.2M-1.0% | $51.7M |
| Gross Profit | $145.5M-4.6% | $152.5M+8.8% | $140.2M+2.7% | $136.5M+4.4% | $130.8M-6.9% | $140.4M+4.6% | $134.2M+8.1% | $124.2M |
| R&D Expenses | $37.8M+11.6% | $33.8M-8.5% | $37.0M-6.7% | $39.6M-13.8% | $45.9M+7.5% | $42.7M-2.6% | $43.9M-0.5% | $44.1M |
| SG&A Expenses | $33.0M+13.4% | $29.1M-12.3% | $33.2M-11.2% | $37.3M+16.1% | $32.2M+0.6% | $32.0M+2.0% | $31.4M+1.3% | $31.0M |
| Operating Income | $15.3M-61.3% | $39.5M+84.5% | $21.4M+196.7% | $7.2M+162.7% | -$11.5M-178.4% | $14.7M+96.0% | $7.5M+242.7% | -$5.2M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | -$50.5M-1766.4% | $3.0M+223.7% | -$2.4M-176.9% | $3.2M+764.5% | -$479K-105.2% | $9.2M-7.7% | $10.0M+48.9% | $6.7M |
| Net Income | $70.9M+77.8% | $39.9M+45.4% | $27.4M+253.9% | $7.7M+223.6% | -$6.3M-155.9% | $11.2M+547.2% | $1.7M+123.1% | -$7.5M |
| EPS (Diluted) | N/A | $0.62+47.6% | $0.42+250.0% | $0.12 | N/A | $0.17+466.7% | $0.03+127.3% | $-0.11 |
RAMP Balance Sheet
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.3B+2.0% | $1.3B+2.3% | $1.2B+0.7% | $1.2B-2.2% | $1.3B+0.5% | $1.3B+4.9% | $1.2B-0.9% | $1.2B |
| Current Assets | $653.1M-3.9% | $679.3M+5.0% | $646.7M+2.3% | $632.4M-3.6% | $656.2M+1.9% | $643.8M+10.6% | $582.1M-0.5% | $585.0M |
| Cash & Equivalents | $379.5M-4.1% | $395.9M+7.2% | $369.4M+1.6% | $363.6M-12.0% | $413.3M+9.7% | $376.8M+11.2% | $338.9M+9.2% | $310.4M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $213.0M-2.7% | $218.8M+0.9% | $216.8M-1.4% | $219.8M+18.1% | $186.2M-11.6% | $210.6M+9.6% | $192.1M-6.9% | $206.3M |
| Goodwill | $502.1M0.0% | $502.2M0.0% | $502.2M0.0% | $502.2M+0.1% | $501.8M0.0% | $501.6M-0.1% | $501.9M0.0% | $501.7M |
| Total Liabilities | $322.2M+5.0% | $306.9M+3.5% | $296.6M+4.3% | $284.3M-8.4% | $310.5M+5.1% | $295.5M+12.4% | $262.8M+3.3% | $254.4M |
| Current Liabilities | $264.8M+5.9% | $250.0M+5.5% | $237.0M+6.6% | $222.4M-10.2% | $247.5M+6.9% | $231.6M+16.1% | $199.5M+5.2% | $189.6M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $972.0M+1.0% | $962.3M+2.0% | $943.8M-0.4% | $947.8M-0.1% | $948.9M-0.9% | $957.7M+2.8% | $932.1M-2.1% | $951.9M |
| Retained Earnings | $1.5B+5.1% | $1.4B+3.0% | $1.3B+2.1% | $1.3B+0.6% | $1.3B-0.5% | $1.3B+0.9% | $1.3B+0.1% | $1.3B |
RAMP Cash Flow Statement
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $58.9M-12.4% | $67.3M+17.2% | $57.4M+462.9% | -$15.8M-125.3% | $62.6M+38.7% | $45.1M-18.8% | $55.6M+696.0% | -$9.3M |
| Capital Expenditures | $289K+78.4% | $162K-72.5% | $589K+75.3% | $336K+14.7% | $293K+3.9% | $282K+17.0% | $241K+6.6% | $226K |
| Free Cash Flow | $58.6M-12.7% | $67.1M+18.1% | $56.8M+451.7% | -$16.2M-125.9% | $62.3M+38.9% | $44.8M-19.0% | $55.4M+679.4% | -$9.6M |
| Investing Cash Flow | -$177K+93.5% | -$2.7M-148.9% | -$1.1M-20.0% | -$917K-295.1% | $470K+137.9% | -$1.2M-105.4% | $22.8M+3937.1% | -$593K |
| Financing Cash Flow | -$76.1M-99.5% | -$38.1M+24.3% | -$50.3M-44.7% | -$34.8M-32.5% | -$26.3M-180.7% | -$9.4M+81.5% | -$50.6M-207.3% | -$16.5M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $75.6M+93.0% | $39.2M-21.5% | $49.9M+67.0% | $29.9M+17.4% | $25.4M+152.0% | $10.1M-79.8% | $49.9M+215.9% | $15.8M |
RAMP Financial Ratios
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.6%-1.3pp | 71.9%+1.7pp | 70.2%+0.1pp | 70.1%+0.8pp | 69.3%-2.6pp | 71.9%-0.5pp | 72.4%+1.8pp | 70.6% |
| Operating Margin | 7.4%-11.2pp | 18.6%+7.9pp | 10.7%+7.0pp | 3.7%+9.8pp | -6.1%-13.6pp | 7.5%+3.5pp | 4.0%+7.0pp | -3.0% |
| Net Margin | 34.4%+15.6pp | 18.8%+5.1pp | 13.7%+9.7pp | 4.0%+7.3pp | -3.3%-9.1pp | 5.7%+4.8pp | 0.9%+5.2pp | -4.3% |
| Return on Equity | 7.3%+3.2pp | 4.1%+1.2pp | 2.9%+2.1pp | 0.8%+1.5pp | -0.7%-1.8pp | 1.2%+1.0pp | 0.2%+1.0pp | -0.8% |
| Return on Assets | 5.5%+2.3pp | 3.1%+0.9pp | 2.2%+1.6pp | 0.6%+1.1pp | -0.5%-1.4pp | 0.9%+0.8pp | 0.1%+0.8pp | -0.6% |
| Current Ratio | 2.47-0.3 | 2.72-0.0 | 2.73-0.1 | 2.84+0.2 | 2.65-0.1 | 2.78-0.1 | 2.92-0.2 | 3.08 |
| Debt-to-Equity | 0.33+0.0 | 0.320.0 | 0.31+0.0 | 0.30-0.0 | 0.33+0.0 | 0.31+0.0 | 0.28+0.0 | 0.27 |
| FCF Margin | 28.4%-3.2pp | 31.6%+3.2pp | 28.4%+36.7pp | -8.3%-41.3pp | 33.0%+10.1pp | 22.9%-6.9pp | 29.8%+35.3pp | -5.4% |
Similar Companies
Frequently Asked Questions
What is Liveramp's annual revenue?
Liveramp (RAMP) reported $812.9M in total revenue for fiscal year 2026. This represents a 9.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Liveramp's revenue growing?
Liveramp (RAMP) revenue grew by 9% year-over-year, from $745.6M to $812.9M in fiscal year 2026.
Is Liveramp profitable?
Yes, Liveramp (RAMP) reported a net income of $146.0M in fiscal year 2026, with a net profit margin of 17.9%.
What is Liveramp's EBITDA?
Liveramp (RAMP) had EBITDA of $96.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Liveramp's gross margin?
Liveramp (RAMP) had a gross margin of 70.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Liveramp's operating margin?
Liveramp (RAMP) had an operating margin of 10.3% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Liveramp's net profit margin?
Liveramp (RAMP) had a net profit margin of 17.9% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Liveramp's return on equity (ROE)?
Liveramp (RAMP) has a return on equity of 15.0% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Liveramp's free cash flow?
Liveramp (RAMP) generated $166.4M in free cash flow during fiscal year 2026. This represents a 8.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Liveramp's operating cash flow?
Liveramp (RAMP) generated $167.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Liveramp's total assets?
Liveramp (RAMP) had $1.3B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Liveramp's capital expenditures?
Liveramp (RAMP) invested $1.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Liveramp spend on research and development?
Liveramp (RAMP) invested $148.1M in research and development during fiscal year 2026.
What is Liveramp's current ratio?
Liveramp (RAMP) had a current ratio of 2.47 as of fiscal year 2026, which is generally considered healthy.
What is Liveramp's debt-to-equity ratio?
Liveramp (RAMP) had a debt-to-equity ratio of 0.33 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Liveramp's return on assets (ROA)?
Liveramp (RAMP) had a return on assets of 11.3% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Liveramp's Altman Z-Score?
Liveramp (RAMP) has an Altman Z-Score of 7.01, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Liveramp's Piotroski F-Score?
Liveramp (RAMP) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Liveramp's earnings high quality?
Liveramp (RAMP) has an earnings quality ratio of 1.15x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Liveramp cover its interest payments?
Liveramp (RAMP) has an interest coverage ratio of 2608.3x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Liveramp?
Liveramp (RAMP) scores 55 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.